ARIXTRA sol inj 2.5 mg/0.5ml 10 ser pré 0.5 ml

7680559370064 CH-55937 B01AX05 06.03.0.
ARIXTRA sol inj 2.5 mg/0.5ml 10 ser pré 0.5 ml
ARIXTRA sol inj 2.5 mg/0.5ml 10 ser pré 0.5 ml
ARIXTRA sol inj 2.5 mg/0.5ml 10 ser pré 0.5 ml
1 / 3
google

Details

Product number
5593701
CPT
-
Packaging group
10
Unit
Spritze(n)
Composition
fondaparinuxum natricum 2.5 mg, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Arixtra 2.5 mg/0.5 ml, Injektionslösung
Injektionslösung
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
25/03/2025
Professional SmPC
Français
25/03/2025
Professional SmPC
Italien
25/03/2025
Patient information leaflet
Allemand
15/10/2024
Patient information leaflet
Français
15/10/2024
Patient information leaflet
Italien
15/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
2.03 MG Substance HBESI

Reimbursement information

Public price
CHF 65.95
Specialties list
Yes
Generic
No
SL addition date: 01/05/2004

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
55937
Drug name
Arixtra, Injektionslösung
Galenic form
LSPA
ATC Code
B01AX05
Authorization status
Z
Dispensation category
B
First authorization
25/06/2002
Authorization expiration date
31/12/9999
IT number
06.03.0.
Domain
Human medicine
Field of application
Antikoagulans

Packaging details

Description (FR)
ARIXTRA sol inj 2.5 mg/0.5ml 10 ser pré 0.5 ml
Description (DE)
ARIXTRA Inj Lös 2.5 mg/0.5ml 10 Fertspr 0.5 ml
Market launch
25/06/2002
Narcotic (BTM)
No

Other packaging sizes

ARIXTRA sol inj 2.5 mg/0.5ml 2 ser pré 0.5 ml
2 SPRI
View
ARIXTRA sol inj 1.5 mg/0.3ml 10 ser pré 0.3 ml
10 SPRI
View
ARIXTRA sol inj 5 mg/0.4ml 2 ser pré 0.4 ml
2 SPRI
View